Refine
Has Fulltext
- yes (11)
Is part of the Bibliography
- yes (11)
Year of publication
- 2015 (11) (remove)
Document Type
- Journal article (11)
Language
- English (11)
Keywords
- acute ischemic stroke (2)
- expression (2)
- multiple sclerosis (2)
- trial (2)
- FTY720-P (1)
- IL-15 (1)
- MIC ligands (1)
- NADPH oxidase inhibitors (1)
- NKG2D (1)
- NKG2D ligands (1)
- Sphingosine 1-Phosphate (1)
- T cell activation (1)
- Zonula Occludens-1 (1)
- acute management of stroke (1)
- acute neurology (1)
- acute stroke imaging (1)
- acute stroke management (1)
- acute stroke outcome (1)
- adherence (1)
- antibodies (1)
- atherosclerosis (1)
- atrial fibrillation (1)
- biomarker (1)
- blood coagulability (1)
- blood-brain barrier (1)
- cardiovascular disease (1)
- celiac disease (1)
- chronic cerebrovascular disease (1)
- chronic kidney disease (1)
- colony-stimulating factor (1)
- cortical pathology (1)
- cutting edge (1)
- darbepoetin alpha (1)
- diabetes mellitus (1)
- disability (1)
- disease (1)
- disease-modifying therapy (1)
- efficacy (1)
- endothelial cells (1)
- endothelin-1 (1)
- experimental autoimmune encephalomyelitis (1)
- focal cerebral ischemia (1)
- guidelines (1)
- human muscle-cells (1)
- idiopathic inflammatory myopathies (1)
- immune cells (1)
- increased risk (1)
- inflammation (1)
- injection site reactions; (1)
- ischemic stroke (1)
- lesions (1)
- leukocytes (1)
- lymphocytes (1)
- lymphokine-activated killer (1)
- matrix metalloproteinases (1)
- mice (1)
- mice impact (1)
- microsphere/macrosphere (1)
- monocytes (1)
- mouse (1)
- natural history (1)
- non-VKA oral anticoagulants (1)
- novo renal transplantation (1)
- oxidative stress (1)
- pathology section (1)
- permanent and transient middle cerebral artery occlusion (1)
- photothrombosis (1)
- polymorphisms inflammation (1)
- polymyositis (1)
- prevention (1)
- quality of life (1)
- randomized controlled trial (1)
- rat (1)
- rat brain microvascular endothelial cell culture (1)
- receptor (1)
- regulatory T cells (1)
- relapsing multiple sclerosis (1)
- relapsing-remitting multiple sclerosis (1)
- scale (1)
- search filter (1)
- stroke (1)
- subcutaneous injection (1)
- therapy (1)
- thromboembolic clot model (1)
- thromboembolic stroke (1)
- thromboinflammation (1)
- tight junctions (1)
- transient ischemic attack (1)
- translational stroke research (1)
- tumor immunity (1)
- vascular permeability (1)
- vitamin K antagonists (1)
- von Willebrand factor (1)
- warfarin (1)
Institute
EU-Project number / Contract (GA) number
- 294683 (1)
From October 31th – November 2nd, 2014, the 6th NEUROWIND e.V. meeting was held in Motzen, Brandenburg, Germany. 70 doctoral students and postdocs from over 25 different groups working in German and Swiss university hospitals or research institutes attended the meeting to discuss their latest experiments and findings in the fields of neuroimmunology, neurodegeneration and neurovascular research. The meeting was regarded as a very well organized platform to support research of young investigators in Germany and all participants enjoyed the stimulating environment for lively in depth discussions.
According to the major aim of NEUROWIND e.V. to support younger researchers in Germany the 4th NEUROWIND YOUNG SCIENTIST AWARD for experimental neurology was awarded to Michael Breckwoldt on his work in the group of Thomas Misgeld (Institute of Neuronal Cell Biology, Technische Universität München, Germany). The successful project was published in Nature Medicine entitled “Multiparametric optical analysis of mitochondrial redox signals during neuronal physiology and pathology in vivo”. This outstanding paper deals with a molecular imaging approach in living mice to optically analyze the role of mitochondrial redox signals in axons in health and disease. The award is endowed with 20.000 Euro sponsored by Merck Serono GmbH, Darmstadt, Germany (unrestricted educational grant).
This year’s keynote lecture was given by Bernhard Hemmer, Head of the Department of Neurology at the Klinikum rechts der Isar, Technische Universität München. Dr. Hemmer highlighted the particular role of B cells and (auto)antibodies in multiple sclerosis (MS). As a new highlight Dr. Urbahns, head of global discovery technologies at Merck research laboratories, gave insights from research practice in the pharmaceutical industry and introduced a shift in the view on present-day drug discovery paradigms.